Progress and potential of exosome analysis for early pancreatic cancer detection

References

• Siegel R, Naishadham D, Jemal A. Cancer statistics 2013. CA Cancer J Clin. 2013;63:11–30.
   PubMed Web of Science ®Google Scholar
• Silvestris N, Gnoni A, Brunetti AE, et al. Target therapies in pancreatic carcinoma. Curr Med Chem. 2014;21:948–965.
   PubMed Web of Science ®Google Scholar
• Wang Z, Lai S-T, Xie L, et al. Metformin is associated with reduced risk of pancreatic cancer in patients with type 2 diabetes mellitus: a systematic review and meta-analysis. Diabetes Res Clin Pract. 2014;106:19–26.
   PubMed Web of Science ®Google Scholar
• Del Chiaro M, Segersvärd R, Lohr M, et al. Early detection and prevention of pancreatic cancer: is it really possible today? World J Gastroenterol. 2014;20:12118–12131.
   PubMed Web of Science ®Google Scholar
• Ansari D, Gustafsson A, Andersson R. Update on the management of pancreatic cancer: surgery is not enough. World J Gastroenterol. 2015;21:3157–3165.
   PubMed Web of Science ®Google Scholar
• Wang X-Y, Yang F, Jin C, et al. Utility of PET/CT in diagnosis, staging, assessment of resectability and metabolic response of pancreatic cancer. World J Gastroenterol. 2014;20:15580–15589.
   PubMed Web of Science ®Google Scholar
• Duffy MJ, Sturgeon CM, Sölétormos G, et al. Validation of new cancer biomarkers: a position statement from the European group on tumor markers. Clin Chem. 2015;61:809–820.
   PubMed Web of Science ®Google Scholar
• Maithel SK, Maloney S, Winston C, et al. Preoperative CA 19-9 and the yield of staging laparoscopy in patients with radiographically resectable pancreatic adenocarcinoma. Ann Surg Oncol. 2008;15:3512–3520.
   PubMed Web of Science ®Google Scholar
• Brand RE, Nolen BM, Zeh HJ, et al. Serum biomarker panels for the detection of pancreatic cancer. Clin Cancer Res. 2011;17:805–816.
   PubMed Web of Science ®Google Scholar
• Ansari D, Andersson R, Bauden MP, et al. Protein deep sequencing applied to biobank samples from patients with pancreatic cancer. J Cancer Res Clin Oncol. 2015;141:369–380.
   PubMed Web of Science ®Google Scholar
• Pan S, Tamura Y, Chen R, et al. Large-scale quantitative glycoproteomics analysis of site-specific glycosylation occupancy. Mol Biosyst. 2012;8:2850–2856.
   PubMed Web of Science ®Google Scholar
• Fukushige S, Horii A. Road to early detection of pancreatic cancer: attempts to utilize epigenetic biomarkers. Cancer Lett. 2014;342:231–237.
   PubMed Web of Science ®Google Scholar
• Yi JM, Guzzetta AA, Bailey VJ, et al. Novel methylation biomarker panel for the early detection of pancreatic cancer. Clin Cancer Res. 2013;19:6544–6555.
   PubMed Web of Science ®Google Scholar
• Nagpal G, Sharma M, Kumar S, et al. PCMdb: pancreatic cancer methylation database. Sci Rep. 2014;4:4197.
   PubMed Web of Science ®Google Scholar
• Jin K, Luo G, Xiao Z, et al. Noncoding RNAs as potential biomarkers to predict the outcome in pancreatic cancer. Drug Des Devel Ther. 2015;9:1247–1255.
   PubMed Web of Science ®Google Scholar
• Zöller M. Pancreatic cancer diagnosis by free and exosomal miRNA. World J Gastrointest Pathophysiol. 2013;4:74–90.
   PubMedGoogle Scholar
• Liu J, Gao J, Du Y, et al. Combination of plasma microRNAs with serum CA19-9 for early detection of pancreatic cancer. Int J Cancer. 2012;131:683–691.
   PubMed Web of Science ®Google Scholar
• Liu R, Chen X, Du Y, et al. Serum microRNA expression profile as a biomarker in the diagnosis and prognosis of pancreatic cancer. Clin Chem. 2012;58:610–618.
   PubMed Web of Science ®Google Scholar
• Schultz NA, Dehlendorff C, Jensen BV, et al. MicroRNA biomarkers in whole blood for detection of pancreatic cancer. Jama. 2014;311:392–404.
   PubMed Web of Science ®Google Scholar
• Li A, Yu J, Kim H, et al. MicroRNA array analysis finds elevated serum miR-1290 accurately distinguishes patients with low-stage pancreatic cancer from healthy and disease controls. Clin Cancer Res. 2013;19:3600–3610.
   PubMed Web of Science ®Google Scholar
• Baraniskin A, Nöpel-Dünnebacke S, Ahrens M, et al. Circulating U2 small nuclear RNA fragments as a novel diagnostic biomarker for pancreatic and colorectal adenocarcinoma. Int J Cancer. 2013;132:E48–57.
   PubMed Web of Science ®Google Scholar
• Wan C, Shen Y, Yang T, et al. Diagnostic value of microRNA for pancreatic cancer: a meta-analysis. Arch Med Sci. 2012;8:749–755.
   PubMed Web of Science ®Google Scholar
• Vlassov AV, Magdaleno S, Setterquist R, et al. Exosomes: current knowledge of their composition, biological functions, and diagnostic and therapeutic potentials. Biochim Biophys Acta. 2012;1820:940–948.
   PubMed Web of Science ®Google Scholar
• Lo Cicero A, Stahl PD, Raposo G. Extracellular vesicles shuffling intercellular messages: for good or for bad. Curr Opin Cell Biol. 2015;35:69–77.
   PubMed Web of Science ®Google Scholar
• Henne WM, Buchkovich NJ, Emr SD. The ESCRT pathway. Dev Cell. 2011;21:77–91.
   PubMed Web of Science ®Google Scholar
• Colombo M, Moita C, van Niel G, et al. Analysis of ESCRT functions in exosome biogenesis, composition and secretion highlights the heterogeneity of extracellular vesicles. J Cell Sci. 2013;126(Pt 24):5553–5565.
   PubMed Web of Science ®Google Scholar
• Baietti MF, Zhang Z, Mortier E, et al. Syndecan-syntenin-ALIX regulates the biogenesis of exosomes. Nat Cell Biol. 2012;14:677–685.
   PubMed Web of Science ®Google Scholar
• Zöller M. Tetraspanins: push and pull in suppressing and promoting metastasis. Nat Rev Cancer. 2009;9:40–55.
   PubMed Web of Science ®Google Scholar
• vanNiel G, Charrin S, Simoes S, et al. The tetraspanin CD63 regulates ESCRT-independent and-dependent endosomal sorting during melanogenesis. DevCell. 2011;21:708–721.
   Google Scholar
• Rana S, Yue S, Stadel D, et al. Toward tailored exosomes: the exosomal tetraspanin web contributes to target cell selection. Int J Biochem Cell Biol. 2012;44:1574–1584.
   PubMed Web of Science ®Google Scholar
• Chairoungdua A, Smith DL, Pochard P, et al. Exosome release of β-catenin: a novel mechanism that antagonizes Wnt signaling. J CellBiol. 2010;190:1079–1091.
   Web of Science ®Google Scholar
• Kajimoto T, Okada T, Miya S, et al. Ongoing activation of sphingosine 1-phosphate receptors mediates maturation of exosomal multi-vesicular endosomes. Nat Commun. 2013;4:2712.
   PubMed Web of Science ®Google Scholar
• Kirkegaard T, Roth AG, Petersen NH, et al. Hsp70 stabilizes lysosomes and reverts Niemann-Pick disease-associatedlysosomal pathology. Nature. 2010;463:549–553.
   PubMed Web of Science ®Google Scholar
• Kelly EE, Horgan CP, Goud B, et al. The Rab family of proteins: 25years on. Biochem Soc Trans. 2012;40:1337–1347.
   PubMed Web of Science ®Google Scholar
• Nabhan JF, Hu R, Oh RS, et al. Formation and release of arrestin domain-containing protein 1-mediated microvesicles (ARMMs) at plasma membrane by recruitment of TSG101 protein. Proc Natl Acad Sci USA. 2012;109:4146–4151.
   PubMed Web of Science ®Google Scholar
• Shen B, Wu N, Yang J-M, et al. Protein targeting to exosomes/microvesicles by plasma membrane anchors. J Biol Chem. 2011;286:14383–14395.
   PubMed Web of Science ®Google Scholar
• Shen B, Fang Y, Wu N, et al. Biogenesis of the posterior pole is mediated by the exosome/microvesicle protein-sorting pathway. J Biol Chem. 2011;286:44162–44176.
   PubMed Web of Science ®Google Scholar
• Rana S, Claas C, Kretz CC, et al. Activation-induced internalization differs for the tetraspanins CD9 and Tspan8: impact on tumor cell motility. Int J Biochem Cell Biol. 2011;43:106–119.
   PubMed Web of Science ®Google Scholar
• Guo BB, Bellingham SA, Hill AF. The neutral sphingomyelinase pathway regulates packaging of the prion protein into exosomes. J Biol Chem. 2015;290:3455–3467.
   PubMed Web of Science ®Google Scholar
• Villarroya-Beltri C, Gutierrez-Vazquez C, Sanchez-Cabo F, et al. Sumoylated hnRNPA2B1 controls the sorting of miRNAs into exosomes through binding to specific motifs. Nat Commun. 2013;4:2980.
   PubMed Web of Science ®Google Scholar
• Vedeler A, Hollås H, Grindheim AK, et al. Multiple roles of annexin A2 in post-transcriptional regulation of gene expression. Curr Protein Pept Sci. 2012;13:401–412.
   PubMed Web of Science ®Google Scholar
• Kogure T, Yan IK, Lin W-L, et al. Extracellular vesicle-mediated transfer of a novel long noncoding RNA TUC339: a mechanism of intercellular signaling in human hepatocellular cancer. Genes Cancer. 2013;4:261–272.
   PubMedGoogle Scholar
• González E, Falcón-Pérez JM. Cell-derived extracellular vesicles as a platform to identify low-invasive disease biomarkers. Expert Rev Mol Diagn. 2015;15:907–923.
   PubMed Web of Science ®Google Scholar
• Gudbergsson JM, Johnsen KB, Skov MN, et al. Systematic review of factors influencing extracellular vesicle yield from cell cultures. Cytotechnology. 2015 Oct 3. [Epub ahead of print].
   PubMedGoogle Scholar
• Subra C, Grand D, Laulagnier K, et al. Exosomes account for vesicle-mediated transcellular transport of activatable phospholipases and prostaglandins. J Lipid Res. 2010;51:2105–2120.
   PubMed Web of Science ®Google Scholar
• Record M, Carayon K, Poirot M, et al. Exosomes as new vesicular lipid transporters involved in cell-cell communication and various pathophysiologies. Biochim Biophys Acta. 2014;1841:108–120.
   PubMed Web of Science ®Google Scholar
• Llorente A, Skotland T, Sylvänne T, et al. Molecular lipidomics of exosomes released by PC-3 prostate cancer cells. Biochim Biophys Acta. 2013;1831:1302–1309.
   PubMed Web of Science ®Google Scholar
• Lesur A, Domon B. Advances in high-resolution accurate mass spectrometry application to targeted proteomics. Proteomics. 2015;15:880–890.
   PubMed Web of Science ®Google Scholar
• Schey KL, Luther JM, Rose KL. Proteomics characterization of exosome cargo. Methods. 2015;87:75–82.
   PubMed Web of Science ®Google Scholar
• Hoshino D, Kirkbride KC, Costello K, et al. Exosome secretion is enhanced by invadopodia and drives invasive behavior. Cell Rep. 2013;5:1159–1168.
   PubMed Web of Science ®Google Scholar
• Mathivanan S, Ji H, Simpson RJ. Exosomes: extracellular organelles important in intercellular communication. J Proteomics. 2010;73:1907–1920.
   PubMed Web of Science ®Google Scholar
• Yue S, Mu W, Erb U, et al. The tetraspanins CD151 and Tspan8 are essential exosome components for the crosstalk between cancer initiating cells and their surrounding. Oncotarget. 2015;10:2366–2384.
   Google Scholar
• Choi D-S, Yang J-S, Choi E-J, et al. The protein interaction network of extracellular vesicles derived from human colorectal cancer cells. J Proteome Res. 2012;11:1144–1151.
   PubMed Web of Science ®Google Scholar
• Ji H, Greening DW, Barnes TW, et al. Proteome profiling of exosomes derived from human primary and metastatic colorectal cancer cells reveal differential expression of key metastatic factors and signal transduction components. Proteomics. 2013;13:1672–1686.
   PubMed Web of Science ®Google Scholar
• Al-Nedawi K, Meehan B, Micallef J, et al. Intercellular transfer of the oncogenic receptor EGFRvIII by microvesicles derived from tumour cells. Nat Cell Biol. 2008;10:619–624.
   PubMed Web of Science ®Google Scholar
• Corcoran C, Rani S, O’Brien K, et al. Docetaxel-resistance in prostate cancer: evaluating associated phenotypic changes and potential for resistance transfer via exosomes. PLoS One. 2012;7:e50999.
   PubMed Web of Science ®Google Scholar
• Park J-A, Sharif AS, Tschumperlin DJ, et al. Tissue factor-bearing exosome secretion from human mechanically stimulated bronchial epithelial cells in vitro and in vivo. J Allergy Clin Immunol. 2012;130:1375–1383.
   PubMed Web of Science ®Google Scholar
• Demory Beckler M, Higginbotham JN, Franklin JL, et al. Proteomic analysis of exosomes from mutant KRAS colon cancer cells identifies intercellular transfer of mutant KRAS. Mol Cell Proteomics. 2013;12:343–355.
   PubMed Web of Science ®Google Scholar
• Kumar D, Gupta D, Shankar S, et al. Biomolecular characterization of exosomes released from cancer stem cells: possible implications for biomarker and treatment of cancer. Oncotarget. 2015;6:3280–3291.
   PubMed Web of Science ®Google Scholar
• Zöller M. Exosomes in cancer disease. Methods Mol Biol. 2016;1381:111–149.
   PubMedGoogle Scholar
• Pinto R, De Summa S, Petriella D, et al. The value of new high-throughput technologies for diagnosis and prognosis in solid tumors. Cancer Biomark. 2014;14:103–117.
   PubMed Web of Science ®Google Scholar
• Iwakawa H-O, Tomari Y. The functions of microRNAs: mRNA decay and translational repression. Trends Cell Biol. 2015;25:651–665.
   PubMed Web of Science ®Google Scholar
• Sato-Kuwabara Y, Melo SA, Soares FA, et al. The fusion of two worlds: non-coding RNAs and extracellular vesicles – diagnostic and therapeutic implications. Int J Oncol. 2015;46:17–27.
   PubMed Web of Science ®Google Scholar
• Garg M. Targeting microRNAs in epithelial-to-mesenchymal transition-induced cancer stem cells: therapeutic approaches in cancer. Expert Opin Ther Targets. 2015;19:285–297.
   PubMed Web of Science ®Google Scholar
• Garofalo M, Croce CM. Role of microRNAs in maintaining cancer stem cells. Adv Drug Deliv Rev. 2015;81:53–61.
   PubMed Web of Science ®Google Scholar
• Katoh M. Therapeutics targeting angiogenesis: genetics and epigenetics, extracellular miRNAs and signaling networks. Int J Mol Med. 2013;32:763–777.
   PubMed Web of Science ®Google Scholar
• Díaz-López A, Moreno-Bueno G, Cano A. Role of microRNA in epithelial to mesenchymal transition and metastasis and clinical perspectives. Cancer Manag Res. 2014;6:205–216.
   PubMed Web of Science ®Google Scholar
• Joglekar MV, Patil D, Joglekar VM, et al. The miR-30 family microRNAs confer epithelial phenotype to human pancreatic cells. Islets. 2009;1:137–147.
   PubMed Web of Science ®Google Scholar
• Ji Q, Hao X, Zhang M, et al. MicroRNA miR-34 inhibits human pancreatic cancer tumor-initiating cells. PLoS One. 2009;4:e6816.
   PubMed Web of Science ®Google Scholar
• Pan X, Wang Z-X, Wang R. MicroRNA-21: a novel therapeutic target in human cancer. Cancer Biol Ther. 2010;10:1224–1232.
   PubMed Web of Science ®Google Scholar
• Khew-Goodall Y, Goodall GJ. Myc-modulated miR-9 makes more metastases. Nat Cell Biol. 2010;12:209–211.
   PubMed Web of Science ®Google Scholar
• Liu C, Kelnar K, Liu B, et al. The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44. Nat Med. 2011;17:211–215.
   PubMed Web of Science ®Google Scholar
• Wu Z-S, Wu Q, Wang C-Q, et al. miR-340 inhibition of breast cancer cell migration and invasion through targeting of oncoprotein c-Met. Cancer. 2011;117:2842–2852.
   PubMed Web of Science ®Google Scholar
• Srivastava A, Filant J, Moxley KM, et al. Exosomes: a role for naturally occurring nanovesicles in cancer growth, diagnosis and treatment. Curr Gene Ther. 2015;15:182–192.
   PubMed Web of Science ®Google Scholar
• Silva A, Bullock M, Calin G. The clinical relevance of long non-coding RNAs in cancer. Cancers (Basel). 2015;7:2169–2182.
   PubMedGoogle Scholar
• Roberts MJ, Chow CW, Schirra HJ, et al. Diagnostic performance of expression of PCA3, Hepsin and miR biomarkers inejaculate in combination with serum PSA for the detection of prostate cancer. Prostate. 2015;75:539–549.
   PubMed Web of Science ®Google Scholar
• Hanna N, Ohana P, Konikoff FM, et al. Phase 1/2a, dose-escalation, safety, pharmacokinetic and preliminary efficacy study of intratumoral administration of BC-819 in patients with unresectable pancreatic cancer. Cancer Gene Ther. 2012;19(6):374–381.
   PubMed Web of Science ®Google Scholar
• Majumder S, Chari ST, Ahlquist DA. Molecular detection of pancreatic neoplasia: current status and future promise. World J Gastroenterol. 2015;21:11387–11395.
   PubMed Web of Science ®Google Scholar
• Ballehaninna UK, Chamberlain RS. Biomarkers for pancreatic cancer: promising new markers and options beyond CA 19-9. Tumour Biol. 2013;34:3279–3292.
   PubMed Web of Science ®Google Scholar
• Ren S, Wang F, Shen J, et al. Long non-coding RNA metastasis associated in lung adenocarcinoma transcript 1 derived miniRNA as a novel plasma-based biomarker for diagnosing prostate cancer. Eur J Cancer. 2013;49:2949–2959.
   PubMed Web of Science ®Google Scholar
• Frampton AE, Krell J, Jamieson NB, et al. microRNAs with prognostic significance in pancreatic ductal adenocarcinoma: a meta-analysis. Eur J Cancer. 2015;51:1389–1404.
   PubMed Web of Science ®Google Scholar
• Madhavan B, Yue S, Galli U, et al. Combined evaluation of a panel of protein and miRNA serum-exosome biomarkers for pancreatic cancer diagnosis increases sensitivity and specificity. Int J Cancer. 2015;136:2616–2627.
   PubMed Web of Science ®Google Scholar
• Tjensvoll K, Nordgård O, Smaaland R. Circulating tumor cells in pancreatic cancer patients: methods of detection and clinical implications. Int J Cancer. 2014;134:1–8.
   PubMed Web of Science ®Google Scholar
• Jung T, Castellana D, Klingbeil P, et al. CD44v6 dependence of premetastatic niche preparation by exosomes. Neoplasia. 2009;11:1093–1105.
   PubMed Web of Science ®Google Scholar
• Costa-Silva B, Aiello NM, Ocean AJ, et al. Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver. Nat Cell Biol. 2015;17:816–826.
   PubMed Web of Science ®Google Scholar
• Ge Q, Zhou Y, Lu J, et al. miRNA in plasma exosome is stable under different storage conditions. Molecules. 2014;19:1568–1575.
   PubMed Web of Science ®Google Scholar
• Colombo M, Raposo G, Théry C. Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles. Annu Rev Cell Dev Biol. 2014;30:255–289.
   PubMed Web of Science ®Google Scholar
• Lässer C, Eldh M, Lötvall J. Isolation and characterization of RNA-containing exosomes. J Vis Exp. 2012;59:e3037.
   PubMed Web of Science ®Google Scholar
• Klepárník K. Recent advances in combination of capillary electrophoresis with mass spectrometry: methodology and theory. Electrophoresis. 2015;36:159–178.
   PubMed Web of Science ®Google Scholar
• Chai EZ, Siveen KS, Shanmugam MK, et al. Analysis of the intricate relationship between chronic inflammation and cancer. Biochem J. 2015;468:1–15.
   PubMed Web of Science ®Google Scholar
• Kalra H, Simpson RJ, Ji H, et al. Vesiclepedia: a compendium for extracellular vesicles with continuous community annotation. PLoS Biol. 2012;10:e1001450.
   PubMed Web of Science ®Google Scholar
• Liu X, Fan D. The epithelial-mesenchymal transition and cancer stem cells: functional and mechanistic links. Curr Pharm Des. 2015;21:1279–1291.
   PubMed Web of Science ®Google Scholar
• Ajani JA, Song S, Hochster HS, et al. Cancer stem cells: the promise and the potential. Semin Oncol. 2015;42(Suppl 1):S3–S17.
   Google Scholar
• Wang H, Rana S, Giese N, et al. Tspan8, CD44v6 and alpha6beta4 are biomarkers of migrating pancreatic cancer-initiating cells. Int J Cancer. 2013;133:416–426.
   PubMed Web of Science ®Google Scholar
• Yoshida K, Sanada M, Ogawa S. Deep sequencing in cancer research. Jpn J Clin Oncol. 2013;43:110–115.
   PubMed Web of Science ®Google Scholar
• Frank TS, Sun X, Zhang Y, et al. Genomic profiling guides the choice of molecular targeted therapy of pancreatic cancer. Cancer Lett. 2015;363:1–6.
   PubMed Web of Science ®Google Scholar
• Du Y, Liu M, Gao J, et al. Aberrant microRNAs expression patterns in pancreatic cancer and their clinical translation. Cancer Biother Radiopharm. 2013;28:361–369.
   PubMed Web of Science ®Google Scholar
• Ding G, Zhou L, Qian Y, et al. Pancreatic cancer-derived exosomes transfer miRNAs to dendritic cells and inhibit RFXAP expression via miR-212-3p. Oncotarget. 2015;6:29877–29888.
   PubMed Web of Science ®Google Scholar
• Beloribi-Djefaflia S, Siret C, Lombardo D. Exosomal lipids induce human pancreatic tumoral MiaPaCa-2 cells resistance through the CXCR4-SDF-1α signaling axis. Oncoscience. 2014;2:15–30.
   PubMedGoogle Scholar
• Kahlert C, Melo SA, Protopopov A, et al. Identification of double-stranded genomic DNA spanning all chromosomes with mutated KRAS and p53 DNA in the serum exosomes of patients with pancreatic cancer. J Biol Chem. 2014;289:3869–3875.
   PubMed Web of Science ®Google Scholar
• Que R, Ding G, Chen J, et al. Analysis of serum exosomal microRNAs and clinicopathologic features of patients with pancreatic adenocarcinoma. World J Surg Oncol. 2013;11:219.
   PubMed Web of Science ®Google Scholar
• Melo SA, Luecke LB, Kahlert C, et al. Glypican-1 identifies cancer exosomes and detects early pancreatic cancer. Nature. 2015;523:177–182.
   PubMed Web of Science ®Google Scholar
• Nagathihalli NS, Castellanos JA, Shi C, et al. Signal transducer and activator of transcription 3, mediated remodeling of the tumor microenvironment results in enhanced tumor drug delivery in a mouse model of pancreatic cancer. Gastroenterology. 2015;149:1932–1943.
   PubMed Web of Science ®Google Scholar
• Arraud N, Linares R, Tan S, et al. Extracellular vesicles from blood plasma: determination of their morphology, size, phenotype and concentration. J Thromb Haemost. 2014;12:614–627.
   PubMed Web of Science ®Google Scholar
• Takahashi Y, Nishikawa M, Shinotsuka H. Visualization and in vivo tracking of the exosomes of murine melanoma B16-BL6 cells in mice after intravenous injection. J Biotechnol. 2013;165:77–84.
   PubMed Web of Science ®Google Scholar
• Mu W, Rana S, Zöller M. Host matrix modulation by TEX promotes motility and invasiveness. Neoplasia. 2013;15:875–887.
   PubMed Web of Science ®Google Scholar
• Hoshino A, Costa-Silva B, Shen TL, et al. Tumour exosome integrins determine organotropic metastasis. Nature. 2015;527:329–335.
   PubMed Web of Science ®Google Scholar
• Franzen CA, Blackwell RH, Foreman KE, et al. Urinary exosomes: the potential for biomarker utility, intercellular signaling, and therapeutics in urologic malignancy. J Urol. 2015;pii:S0022–S5347.
   Google Scholar
• Szul T, Bratcher PE, Fraser K, et al. Toll-like receptor 4 engagement mediates prolyl endopeptidase release from airway epithelia via exosomes. Am J Respir Cell Mol Biol. 2016;54:359–369
   PubMed Web of Science ®Google Scholar
• Kowal J, Tkach M, Théry C. Biogenesis and secretion of exosomes. Curr Opin Cell Biol. 2014;29:116–125.
   PubMed Web of Science ®Google Scholar
• Thuma F, Zöller M. Outsmart tumor exosomes to steal the cancer initiating cell its niche. Semin Cancer Biol. 2014;28:39–50.
   PubMed Web of Science ®Google Scholar
• Amato E, Molin MD, Mafficini A, et al. Targeted next-generation sequencing of cancer genes dissects the molecular profiles of intraductal papillary neoplasms of the pancreas. J Pathol. 2014;233:217–227.
   PubMed Web of Science ®Google Scholar
• Gayral M, Jo S, Hanoun N, et al. MicroRNAs as emerging biomarkers and therapeutic targets for pancreatic cancer. World J Gastroenterol. 2014;20:11199–11209.
   PubMed Web of Science ®Google Scholar
• Moir JA, White SA, Mann J. Arrested development and the great escape – the role of cellular senescence in pancreatic cancer. Int J Biochem Cell Biol. 2014;57:142–148.
   PubMed Web of Science ®Google Scholar